表紙
市場調査レポート

ポーランドの体外診断 (IVD) 市場

In vitro diagnostics market in Poland 2014 - Development forecasts for 2014-2019

発行 PMR 商品コード 107918
出版日 ページ情報 英文 154 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
ポーランドの体外診断 (IVD) 市場 In vitro diagnostics market in Poland 2014 - Development forecasts for 2014-2019
出版日: 2014年12月30日 ページ情報: 英文 154 Pages
概要

当レポートでは、ポーランドの体外診断(IVD)市場について詳細に分析し、将来予測と同市場に参入する大手企業の市場シェアとプロファイル、法規制動向などについてまとめています。

調査手法

エグゼクティブサマリー

ポーランドにおける体外診断市場の概要

  • 試験所診断市場の主な出来事と動向
  • 試験所診断市場において今後予測される動向と発展
  • 体外診断市場の売上

IVD市場の各セグメント別分析

  • ポーランドのIVD市場の主要セクター
  • ポーランドのIVD市場の主要セグメント
    • 試薬
    • 器具
    • 臨床化学
    • 免疫学・免疫化学
    • 血液学、組織学、細胞学
    • 微生物学
    • 分子診断

ポーランドの体外診断市場の主要企業

  • 海外企業
  • ポーランド企業

診断試験所

  • 市場概要
  • アウトソーシング
  • 試験所の数と種類
  • 試験所の所在地
  • 主要試験所のプロファイル
  • 検査の質

対外貿易

検査に対する消費者の姿勢と支出

  • 予防的検査
  • 試験所での検査に対する支出

法的環境

  • 法的基盤
  • 製造
  • サービス

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

This report provides readers with widely understood analysis of the in vitro diagnostic market. It describes and simplifies market structure, offers profiles of the most influential equipment manufacturers and testing services providers and contains forecasts for market growth from 2014-2019. It contains also information pertaining to consumer behavior in IVD context.

The document also includes Poland's newest import and export data.

This report focuses on your main market priorities

  • Value of the overall IVD market in Poland and key segments - clinical chemistry, immunochemistry, products for diabetics, haematology/histology/cytology, microbiology and molecular diagnostics
  • Data describing import and export activities on this market from 2004 to H1 2014.
  • The behaviour of patients in Poland with respect to diagnostic testing.
  • IVD reagents, equipment and device manufacturers and largest chains of diagnostic laboratories at work on the Polish market - represented by detailed company profiles
  • Future development - as predicted in detailed forecasts covering the period from 2014-2019.

Obtain answers to your most urgent questions

  • What are the greatest growth drivers and market challenges on the IVD market in Poland?
  • Which IVD company operating on the Polish market was awarded the most valuable tenders in 2014?
  • Which devices do IVD companies in Poland manufacture in the highest volume?
  • What is the current value of patient expenditures on Poland's IVD market?
  • How often do patients in Poland undergo laboratory testing?
  • Which segment of this market - clinical chemistry, immunochemistry, diabetes products, haematology/histology/cytology, or microbiology and molecular diagnostics - has the highest value?
  • Which diagnostics laboratories offer outsourcing capabilities?
  • Which testing chains are active in Poland? Which offer the most testing centre locations, and how many tests do they provide?

Exclusive report content includes

  • Comprehensive, highly detailed forecasts for growth and development on all segments of Poland's IVD market for 2014-2019
  • Expert analyses of the market's IVD device and equipment manufacturing segment, as well as the testing services provision segment
  • Study and evaluation of the structure of the IVD market in Poland that includes complete coverage of all major segments.

Did you know that

  • Polish market of IVD equipment and reagents, similarly to other countries worldwide, is dominated by the largest international medical companies.
  • International key players on the market of producers/distributors are such companies as Roche, Siemes, Abbot, bioMerieux.
  • Local key players worth mentioning are PZ Cormay, BioMaxima and Bor-Pol.
  • Market consolidation is one of the main trends in IVD market. It has an impact on both producers' and diagnostic laboratories' segments.
  • The Reimbursement Act changed the reimbursement ratio for IVD products. The change of rules for drug funding had the greatest impact on the sector of test strips used in diabetology. In 2012, the reimbursement ratio for blood glucose test strips dropped by 51%.
  • The Regulation by the Ministry of Health, which came into force in November 2014, expanded the list of laboratory diagnostic health services by complete blood count, blood chemistry and immunoassay blood tests having a significant impact on IVD market.
  • The market share of expenditures on laboratory diagnostics in Poland reaches one of the lowest levels among OECD countries. Therefore, also the level of per capita expenditures on laboratory diagnostics in Poland is fairly low compared to other countries.

A diverse group of PMR clients use this report to

  • Initiate new operations on the IVD devices and services market in Poland
  • Plan expansion of currently operating laboratory chains
  • Calculate forecasts for industry development
  • Create a portfolio of high-demand products
  • Locate merger or acquisition opportunities
  • Conduct competition research
  • Assess the potential for continued growth on this market.

Extract from this report

  • In 2012 the value of IVD market in Poland was reduced by 14%, which was the result of the coming into force of the Reimbursement Act. The provisions of the act had a tremendous impact on the value of the blood glucose test strip segment. Pursuant to NFZ data, in 2012 the reimbursement ratio for the products, compared to last year, was reduced by 50%, and in 2013, NFZ expenditures on IVD products' reimbursement were reduced by 44% compared to 2011.
  • Over the past few years a downward trend has been identified in the share of public laboratories in the quantity of laboratories in total. At the same time, the share of private healthcare facilities increased.
  • The segment of clinical chemistry makes up the largest share in IVD market in Poland.

Market commentary by expert

“In 2012 the value of IVD market in Poland dropped to 14%, which resulted from the coming into force of the Reimbursement Act. The market stagnation in 2012 was caused, mainly, by the provisions of the Act, which had a negative impact on the diabetic products segment (sales of glucose test strips). Changes of the reimbursement ratio for blood glucose test strips had a significant impact on the market as the sales of test strips in 2011 accounted for 44% of the total IVD market value. In 2013 the value of IVD market increased due to the low base from last year and market factors such as financial condition of healthcare facilities (in 2013 hospital debt was significantly reduced).” Malgorzata Kuskowska, Pharmaceutical Market Analyst.

Table of Contents

  • Methodology
  • Executive summary
  • Overview of the in vitro diagnostics market in Poland
    • Key events and trends on the laboratory diagnostic market in 2012-2014
    • Expected events and trends on the laboratory diagnostic market in 2014-2019
    • Value of the market in 2004-2019
  • Analysis of individual segments of the laboratory diagnostics market
    • Key sectors of the IVD market in Poland
    • Key segments of the IVD market in Poland
      • Reagents
      • Apparatus
      • Clinical chemistry
      • Products for diabetics
      • Immunology and immunochemistry
      • Haematology, histology and cytology
      • Microbiology
      • Molecular diagnostics
  • Key manufacturers /distributors in the IVD market in Poland
    • Foreign companies
    • Polish players
    • Participation in tenders
  • Diagnostic laboratories
    • Market overview
    • Outsourcing
    • Number and type of laboratories
    • Location of laboratories
    • Profiles of selected top market players
    • Quality of testing
  • Foreign trade
    • Diagnostic and laboratory reagents
      • Import
      • Export
    • Blood-grouping reagents
      • Import
      • Export
    • Opacifying preparations for x-ray examinations; diagnostic reagents for administration to patients
      • Import
      • Export
  • Consumer behaviour
    • Expenditure on tests
      • Poland in comparison to other countries
      • Performing paid-for laboratory tests
    • Approach to laboratory testing
      • Cytology
  • Legal environment
    • Legal foundations
      • Manufacturing
      • Introduction onto the market
    • Services
      • Funding of tests by the NFZ
    • Diagnostician profession

List of Graphs

  • Value (PLN m) and change (%) of the laboratory diagnostics market in Poland, 2004-2019
  • Forecast for sales value growth of individual IVD market segments in Poland (CAGR, %), 2015-2019
  • Total due debt of independent public healthcare centres in Poland (PLN bn) and change (%), Q1 2010-Q2 2014
  • Total debt of independent public healthcare centres in Poland (PLN bn) and change (%), Q1 2010-Q2 2014
  • Value (PLN bn) and change (%) of the private healthcare market in Poland, 2009-2018
  • Value (PLN m) and change (%) of the laboratory diagnostics market in Poland, 2004-2019
  • Shares of the Polish IVD market sectors by value (%), 2012
  • Shares of the Polish IVD market sectors by value (%), 2013
  • Shares of selected segments of the IVD market in Poland by value (%), 2012
  • Shares of selected segments of the IVD market in Poland by value (%), 2013
  • CAGR for sales value of individual IVD market segments in Poland (%), 2006-2013
  • Forecast for sales value (CAGR) of individual IVD market segments in Poland (%), 2015-2019
  • Share by value for selected categories in the reagents segment of the IVD market in Poland (%), 2012
  • Share by value for selected categories in the reagents segment of the IVD market in Poland (%), 2013
  • Share by value for selected categories in the supply of reagents segment in the IVD market in Poland (%), 2012
  • Share by value for selected categories in the supply of reagents segment in the IVD market in Poland (%), 2013
  • Share by value for selected categories in the equipment segment of the IVD market in Poland (%), 2012
  • Share by value for selected categories in the equipment segment of the IVD market in Poland (%), 2013
  • Value (PLN m) and change (%) of the clinical chemistry segment of the IVD market in Poland, 2010-2019
  • Value structure of sales of reagents used in clinical chemistry in Poland (%), 2012
  • Value structure of sales of reagents used in clinical chemistry in Poland (%), 2013
  • CAGR for sales value of individual categories of reagents used in clinical chemistry in Poland (%), 2008-2013
  • Share of rapid tests for diabetics category in the IVD market value in Poland (%), 2011-2013
  • Share of POZ doctors in prescribing blood glucose meter strips (%), 2011-H1 2014
  • Value (PLN m) and change (%) of tests for the diabetics segment of the IVD market in Poland, 2005-2008 and 2010-2019
  • Value (PLN m) and change (%) of the immunology and immunochemistry segment of the IVD market in Poland, 2010-2019
  • CAGR for sales value of specific categories of reagents used in immunochemistry and immunology in Poland (%), 2008-2013
  • Value structure of sales of reagents used in infectious immunology in Poland (%), 2012
  • Value structure of sales of reagents used in infectious immunology in Poland (%), 2013
  • CAGR for sales value of selected categories of reagents used in infectious immunology in Poland (%), 2008-2013
  • Value structure of sales of instruments used in chemistry and immunochemistry in Poland (%), 2012
  • Value structure of sales of instruments used in chemistry and immunochemistry in Poland (%), 2013
  • CAGR for sales value of selected categories of instruments used in chemistry and immunochemistry in Poland (%), 2008-2013
  • Value (PLN m) and change (%) of the haematology, histology and cytology segment of the IVD market in Poland, 2010-2019
  • Value structure of sales of reagents used in haematology, histology and cytology in Poland (%), 2012
  • Value structure of sales of reagents used in haematology, histology and cytology in Poland (%), 2013
  • CAGR for sales value of individual categories of reagents used in haematology, histology and cytology in Poland (%), 2008-2013
  • Value structure of sales of instruments used in haematology, histology and cytology in Poland (%), 2012
  • Value structure of sales of instruments used in haematology, histology and cytology in Poland (%), 2013
  • CAGR for sales value of individual categories of instruments used in haematology, histology and cytology in Poland (%), 2008-2013
  • Value (PLN m) and change (%) of the microbiology segment of the IVD market in Poland, 2010-2019
  • Value structure of sales of reagents used in microbiology in Poland (%), 2012
  • Value structure of sales of reagents used in microbiology in Poland (%), 2013
  • Value structure of sales of instruments used in microbiology in Poland (%), 2012
  • Value structure of sales of instruments used in microbiology in Poland (%), 2013
  • CAGR for sales value of individual categories of reagents and apparatus used in microbiology in Poland (%), 2008-2013
  • Value of the molecular diagnostics segment of the IVD market in Poland (PLN m), 2005-2008 and 2010-2012
  • Value (PLN m) and change (%) of the molecular diagnostics segment of the IVD market in Poland, 2010-2019
  • Value of reimbursement (PLN m) and number of reimbursed packages of Accu-Chek (‘000) in Poland, 2013
  • Value of reimbursement (PLN m) and number of reimbursed packages of Accu-Chek (‘000) in Poland, January-July 2014
  • Contribution of the Polish division to global revenue of Roche Diagnostics (%), 2006-2012
  • Value of reimbursement (PLN m) and number of reimbursed packages of Omega and Xido strips (‘000) in Poland, 2013
  • Value of reimbursement (PLN m) and number of reimbursed packages of Omega and Xido strips (‘000) in Poland, January-July 2014
  • Revenue from sales and net profit of bioMerieux Polska Sp. z o.o. in Poland (PLN m), 2006-2012
  • Contribution of the Polish division to global revenue of bioMerieux (%), 2006-2012
  • Revenue from sales and net financial result of Siemens Healthcare Diagnostics in Poland (PLN m), 2007-2010
  • Revenue from sales and net financial result of Johnson & Johnson Poland Sp. z o.o. in Poland (PLN m), 2007-2012
  • Revenue from sales and net profit of Werfen Polska Sp. z o.o. in Poland (PLN m), 2012-2013
  • Revenue from sales and net profit of Comesa in Poland (PLN m), 2006-2011
  • Revenue from sales and net profit of Becton Dickinson in Poland (PLN m), 2005/2006-2012/2013
  • Revenue from sales and net profit of Sysmex in Poland (PLN m), 2005/2006-2012/2013
  • Revenue from sales and net financial result of Biomedika in Poland (PLN m), 2005/2006-2006/2007 and 2008/2009-2012/2013
  • Revenue from sales and net profit of Genexo (PLN m), 2007-2013
  • Revenue from export sales of PZ Cormay SA (PLN m) and change (%), 2004-H1 2014
  • Structure of export sales for PZ Cormay SA, by country (%), 2013
  • Structure of export sales for PZ Cormay SA, by country (%), H1 2014
  • Revenue from domestic sales of PZ Cormay SA (PLN m) and change (%), 2004-H1 2014
  • Revenue from sales of BioMaxima in Poland (PLN m) and change (%), 2008-H1 2014
  • Structure of sales for BioMaxima, by segment (%), H1 2014
  • Revenue from sales and net financial result of Hand-Prod Sp. z o.o. in Poland (PLN m), 2006-2012
  • Revenue from sales and net profit of Transfarm Sp. z o.o. in Poland (PLN m), 2007-2012
  • Revenue from sales and net financial result of Bio-Ksel Sp. z o.o. in Poland (PLN m), 2011-2013
  • Number of tenders for the purchase/lease of equipment and IVD reagents won by selected largest companies in Poland (PLN m), January-October 2014
  • Value of tenders for the purchase/lease of equipment and IVD reagents won by selected largest companies in Poland (PLN m), January-October 2014
  • Average value of order for purchase/lease of equipment and IVD reagents obtained in tenders won by selected largest companies in Poland (PLN ‘000), January-October 2014
  • Share of public and private laboratories in total number of laboratories in Poland (%), September 2014
  • Number of facilities performing laboratory tests in Poland, by voivodship, September 2014
  • Number of facilities performing laboratory tests in Poland (per 100,000 residents), by voivodship, September 2014
  • Value of Diagnostyka Sp. z o.o. contract with NFZ in Poland (PLN '000) and change (%), 2009-2014
  • Revenue and net profit of Diagnostyka Sp. z o.o. in Poland (PLN m), 2007-2013
  • Revenue and net profit of Diagnostyka Consilio Sp. z o.o. in Poland (PLN m), 2010-2011
  • Revenue and net profit of Laboratoria Medyczne Loma Sp. z o.o. in Poland (PLN m), 2008-2013
  • Revenue and net profit of Medica Sp. z o.o. in Poland (PLN m), 2008-2013
  • Revenue and net profit of Alab Laboratoria Sp. z o.o. in Poland (PLN m), 2008-2013
  • Revenue and net financial result of Laboratorium Przygoda Sp. z o.o. in Poland (PLN m), 2009-2012
  • Revenue and net financial result of Laboratoria Medyczne Bruss Alab Sp. z o.o. Group in Poland (PLN m), 2007-2012
  • Revenue and net profit of Vitalabo Sp. z o.o. NZOZ in Poland (PLN m), 2006 and 2008-2012
  • Revenue and net financial result of Bialostockie Centrum Analiz Medycznych Sp. z o.o. in Poland (PLN m), 2008-2012
  • Revenue and net profit of bio-Diagnostyka Sp. z o.o. in Poland (PLN m), 2007-2012
  • Revenue and net financial result of Synevo Sp. z o.o. in Poland (PLN m), 2005-2012
  • Imports of diagnostic and laboratory reagents to Poland (PLN m) and change (%), 2004-H1 2014
  • Imports of diagnostic and laboratory reagents to Poland (%), by country, H1 2014
  • Exports of laboratory and diagnostic reagents from Poland (PLN m) and change (%), 2010-H1 2014
  • Exports of diagnostic and laboratory reagents from Poland (%), by country, H1 2014
  • Imports of blood-grouping reagents to Poland (PLN m) and change (%), 2004-H1 2014
  • Imports of blood-grouping reagents to Poland (%), by country, H1 2014
  • Exports of blood-grouping reagents from Poland (PLN m) and change (%), 2009-H1 2014
  • Exports of blood-grouping reagents from Poland (%), by country, H1 2014
  • Imports of opacifying preparations for x-ray examinations and diagnostic reagents for administration to patients to Poland (PLN m) and change (%), 2004-H1 2014
  • Imports of opacifying preparations for x-ray examinations and diagnostic reagents for administration to patients to Poland (%), by country, H1 2014
  • Exports of opacifying preparations for x-ray examinations and diagnostic reagents for administration to patients from Poland (PLN m) and change (%), 2004-H1 2014
  • Exports of opacifying preparations for x-ray examinations and diagnostic reagents for administration to patients from Poland (%), by country, H1 2014
  • Expenditure on laboratory diagnostics in Poland compared to selected other countries, as a % of total expenditure on health, 2012
  • Expenditure on laboratory diagnostics in Poland compared to some other countries, as a % of GDP, 2012
  • Expenditure on laboratory diagnostics in Poland compared to selected other countries, per capita ($), by purchasing power parity, 2012
  • Proportion of people declaring the use of medical services in Poland (%), by type of service, June 2014
  • Main motivation for the use of paid-for services provided by an analytical laboratory or other diagnostic laboratory in Poland (%), June 2014
  • Spending on the last non-reimbursed laboratory test by young Poles (%), March 2013
  • Time range when young Poles had a laboratory test performed (%), March 2013
  • Reasons for not having laboratory tests performed by young Poles (%), March 2013
  • Cytological tests performed by young Poles (%), by age, January 2013
  • Cytological tests performed by young Poles (%), by place of residence, January 2013
  • Cytological tests performed by young Poles (%), by education, January 2013

List of Tables

  • Key events and market trends, and their impact on the in vitro diagnostics market in Poland, 2012-2014
  • Number of biochemical analysers in hospitals in Poland, by voivodship, 2013
  • Number of diagnosticians in Polish voivodships, by specialisation, August 2014
  • Number of laboratory diagnostics specialists (diagnosticians with specialisation and physicians) employed at healthcare facilities in Poland, by specialisation degree and selected degrees of specialisation, 2013
  • Number of physicians with a laboratory diagnostician specialisation in Poland, by specialisation degree, September 2014
  • Key future events and market trends, and their impact on the in vitro diagnostics market in Poland, 2014-2019
  • Value structure of sales of reagents used in immunochemistry and immunology in Poland (%), 2012
  • Value structure of sales of reagents used in immunochemistry and immunology in Poland (%), 2013
  • General information about Roche Diagnostics Polska Sp. z o.o., 2014
  • Revenue from sales and net profit of Roche Diagnostics in Poland (PLN m), 2006-2012
  • Selected tenders for the purchase/lease of equipment and IVD reagents won by Roche Diagnostics in Poland, January-October 2014
  • General information about Abbott Laboratories Polska Sp. z o.o., 2014
  • Revenue from sales and net profit of Abbott Laboratories Poland Sp. z o.o. in Poland (PLN m), 2005/2006-2008/2009 and 2010-2012
  • Selected tenders for the purchase/lease of equipment and IVD reagents won by Abbott Laboratories in Poland, January-October 2014
  • General information about bioMerieux Polska Sp. z o.o., 2014
  • Selected tenders for the purchase/lease of equipment and IVD reagents won by bioMerieux in Poland, January-October 2014
  • General information about Siemens Healthcare, 2014
  • Selected tenders for the purchase/lease of equipment and IVD reagents won by Siemens Healthcare in Poland, January-October 2014
  • General information about Johnson & Johnson Poland Sp. z o.o., 2014
  • Selected tenders for the purchase/lease of equipment and IVD reagents won by Johnson & Johnson in Poland, January-October 2014
  • General information about Werfen Poland Sp. z o.o., 2014
  • Selected tenders for the purchase/lease of equipment and IVD reagents won by Werfen in Poland, January-October 2014
  • General information about Becton Dickinson Poland Sp. z o.o., 2014
  • Selected tenders for the purchase/lease of equipment and IVD reagents won by Becton Dickinson in Poland, January-October 2014
  • General information about Sysmex Polska Sp. z o.o., 2014
  • Selected tenders for the purchase/lease of equipment and IVD reagents won by Sysmex in Poland, January-October 2014
  • General information about Biomedica Poland Sp. z o.o., 2014
  • Selected tenders for the purchase/lease of equipment and IVD reagents won by Biomedica in Poland, January-October 2014
  • General information about Genexo, 2014
  • General information about PPHU Bor-Pol, 2014
  • Selected tenders for the purchase/lease of equipment and IVD reagents won by Bor-Pol in Poland, January-October 2014
  • General information about PZ Cormay SA, 2014
  • Structure of domestic sales for PZ Cormay, by segment (%), 2013
  • Structure of domestic sales for PZ Cormay, by segment (%), H1 2014
  • Selected tenders for the purchase/lease of equipment and IVD reagents won by PZ Cormay in Poland, January-October 2014
  • General information about BioMaxima, 2014
  • Selected tenders for the purchase/lease of equipment and IVD reagents won by BioMaxima in Poland, January-October 2014
  • General information about Hand-Prod, 2014
  • General information about Transfarm Sp. z o.o., 2014
  • Selected tenders for the purchase/lease of equipment and IVD reagents won by Transfarm in Poland, January-October 2014
  • General information about Bio-Ksel Sp. z o.o., 2014
  • Selected tenders for the purchase/lease of equipment and IVD reagents won by Bio-Ksel in Poland, January-October 2014
  • Number of outsourcing locations of selected largest laboratory chains in Poland, November 2014
  • Structure of the largest laboratory chains in Poland and the number of laboratories and specimen collection service points, November 2014
  • Number of tests/markers offered by selected largest laboratory chains in Poland, 2014
  • Estimated number of determinations carried out annually by selected largest laboratory chains in Poland (million), 2014
  • General information regarding operations of Grupa Diagnostyka in Poland, 2014
  • Laboratories operated on an outsourcing basis by Diagnostyka Sp z o.o. in Poland, November 2014
  • Selected laboratories operated on an outsourcing basis by Dr n. med. Teresa Fryda Laboratorium Medyczne Sp. z o. o. in Poland, November 2014
  • General information regarding operations of Grupa Alab in Poland, 2014
  • Selected laboratories operated on an outsourcing basis by Alab Group in Poland, November 2014
  • General information regarding operations of Synevo Sp. z o.o. in Poland, 2014
  • Selected laboratories operated on an outsourcing basis by Synevo in Poland, November 2014
  • Number of certificates granted to microbiological laboratories under the Polmicro programme in Poland, 1998-2013
  • Laboratory tests quality assessment programmes conducted by the Centre for Quality Research in Laboratory Diagnostics in Poland, 2014
  • Principles of classification of products for in vitro diagnostic into Schedules A and B in Poland, 2014
  • Guaranteed laboratory tests in outpatient specialist health care in Poland, by category, as of 1 January 2015
  • List of diagnostic tests ordered and financed by primary care doctors, which are required when offering primary healthcare benefits in Poland, 2014
Back to Top